Author

Seamus P. Ragan

Observed name: Seamus Ragan

Observed institutions: Amgen (United States), University of Washington, Bristol-Myers Squibb (United States), Chinook Therapeutics (United States), Juno Therapeutics (United States), University of Virginia

ORCID: 0000-0002-0836-1236

Observed ORCID: 0000-0002-0836-1236

OpenAlex ID: A5012574636

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

2015 · Kevin J. Hamblett, Allison P. Jacob, et al. · Cancer Research · 148

Identification of a novel human phosphatidic acid phosphatase type 2 isoform

1998 · Shelley B. Hooks, Seamus P. Ragan, et al. · FEBS Letters · 91

Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib

2020 · Jim S. Qin, Timothy G. Johnstone, et al. · Journal of Immunotherapy · 79

Characterization of a Receptor Subtype-Selective Lysophosphatidic Acid Mimetic

1998 · Shelley B. Hooks, Seamus P. Ragan, et al. · Molecular Pharmacology · 52

Expamers: a new technology to control T cell activation

2020 · Mateusz P. Poltorak, Patricia Graef, et al. · Scientific Reports · 39

PDF

Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment

2013 · Olivier Nolan-Stevaux, Donato Tedesco, et al. · PLoS ONE · 38

PDF

Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani population

2017 · Mohsin Shahzad, Sairah Yousaf, et al. · Scientific Reports · 35

PDF

Structure−Activity Relationships of Lysophosphatidic Acid: Conformationally Restricted Backbone Mimetics

1999 · Darrin W. Hopper, Seamus P. Ragan, et al. · Journal of Medicinal Chemistry · 24

Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al. · Molecular Cancer Therapeutics · 16

PDF

Tumor gene signature associated with neurotoxicity in R/R B-ALL patients treated with JCAR015, a CD19-directed CAR T cell product.

2018 · N. Eric Olson, Seamus P. Ragan, et al. · Journal of Clinical Oncology · 4

MO264: Selective Endothelin a Receptor Antagonist Atrasentan Attenuates Mesangial Cell Injury, Proteinuria and intra-renal proliferative, inflammatory and Fibrotic Transcriptional Networks in a Rat Model of Mesangioproliferative Glomerulonephritis

2022 · Eric Olson, Mark Mcconnell, et al. · Nephrology Dialysis Transplantation · 3

PDF

A Multi-Omics Approach to IgA Nephropathy Characterization in the NURTuRE Cohort Enables Precision-Based Treatment Approaches

2022 · N. E. Olson, Jennifer H. Cox, et al. · Journal of the American Society of Nephrology · 1

TGFBR1 Inhibition Attenuates Expansion of Maladaptive Tubule Cells and Ameliorates Kidney Function Decline in the Adenine Nephropathy Mouse Model of CKD

2024 · Shawn S. Badal, Jay Kuo, et al. · Journal of the American Society of Nephrology

Identification of Noninvasive Biomarkers Reflecting Cellular Mechanisms of Endothelin A (ETA) Receptor Activity and Atrasentan Response in CKD

2023 · N. Eric Olson, Tobias Bohnenpoll, et al. · Journal of the American Society of Nephrology

Identification of Surrogate Biomarkers Reflecting Tubular Failed Repair in CKD

2023 · Tobias Bohnenpoll, I-Ju Lo, et al. · Journal of the American Society of Nephrology

Supplementary Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

PDF

Supplementary Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Supplementary Methods from SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm